A Randomized, Double-Blind, Placebo-Controlled Evaluation of the Safety, Efficacy, and Pharmacokinetics of Multiple Doses of Basiliximab, With Concomitant Corticosteroids, in Steroid-Refractory Ulcerative Colitis
Phase of Trial: Phase II
Latest Information Update: 05 Mar 2018
At a glance
- Drugs Basiliximab (Primary) ; Prednisone
- Indications Ulcerative colitis
- Focus Therapeutic Use
- Sponsors Cerimon Pharmaceuticals
- 28 Apr 2012 Primary endpoint 'Remission-rate' has not been met according to results published in Gastroenterology.
- 28 Apr 2012 Results published in Gastroenterology.
- 06 Oct 2009 New trial record.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History